https://www.invitae.com/en/news/2015/02/11/invitae-announces-pricing-initial-public-offering-common-stock 2021-10-10 https://www.invitae.com/en/news 2021-10-10 https://www.invitae.com/en/news/categories/press 2021-10-10 https://www.invitae.com/en/press-releases/2012 2021-10-10 https://www.invitae.com/en/press-releases/2013 2021-10-10 https://www.invitae.com/en/press-releases/2014 2021-10-10 https://www.invitae.com/en/press-releases/2016 2021-10-10 https://www.invitae.com/en/press-releases/2015 2021-10-10 https://www.invitae.com/en/press-releases/2017 2021-10-10 https://www.invitae.com/en/press/JAMA-study-prostate-cancer 2021-10-10 https://www.invitae.com/en/press/asco-data-shows-prostate-cancer-patients-genetic-risk-factors-missed-under-current-testing-guidelines 2021-10-10 https://www.invitae.com/en/press-releases/2018 2021-10-10 https://www.invitae.com/en/press-releases/2019 2021-10-10 https://www.invitae.com/en/press/charcot-marie-tooth-association-announces-educational-sponsorship-invitae 2021-10-10 https://www.invitae.com/en/press/clinical-prevalence-and-properties-deletions-and-duplications-within-disease-genes 2021-10-10 https://www.invitae.com/en/press/behind-seizure-program-expansion 2021-10-10 https://www.invitae.com/en/press/company-formation 2021-10-10 https://www.invitae.com/en/press/ascogu-prostate-sartor 2021-10-10 https://www.invitae.com/en/press/data-rare-diseases-presented-ACMG-impact-survey 2021-10-10 https://www.invitae.com/en/press/genome-code-talkers-contest-GCs 2021-10-10 https://www.invitae.com/en/press/international-initiative-applauds-supreme-court-decision-eliminating-gene-patents-and-announces-launch-public-database-hereditary-gene-mutations 2021-10-10 https://www.invitae.com/en/press/invitae-35th-jp-morgan-healthcare-conference 2021-10-10 https://www.invitae.com/en/press/genetic-counselors-recognized-patients-peers 2021-10-10 https://www.invitae.com/en/press/invitae-ASRM 2021-10-10 https://www.invitae.com/en/press/invitae-acquires-altavoice 2021-10-10 https://www.invitae.com/en/press/invitae-acquires-cancergene-connect 2021-10-10 https://www.invitae.com/en/press/invitae-Q1-2019-earnings 2021-10-10 https://www.invitae.com/en/press/invitae-Q4-FY-2018-earnings 2021-10-10 https://www.invitae.com/en/press/invitae-acquiring-good-start-genetics-and-combimatrix-adding-comprehensive-reproductive-health-capabilities-serve-every-stage-life 2021-10-10 https://www.invitae.com/en/press/invitae-adds-two-genes-TAT-STAT 2021-10-10 https://www.invitae.com/en/press/invitae-and-collaborators-present-new-data-2015-american-society-clinical-oncology-annual-meeting-focusing-clinical-utility-multi-gene-panel-tests-hereditary-breast-and-ovarian-cancer 2021-10-10 https://www.invitae.com/en/press/invitae-and-collaborators-present-data-san-antonio-breast-cancer-symposium-demonstrating-use-multi-gene-panels-reliable-risk-assessment-hereditary-breastovarian-cancer-patients 2021-10-10 https://www.invitae.com/en/press/invitae-and-nanopharmacia-announce-partnership-make-reliable-fast-and-affordable-hereditary-cancer-genetic-testing-broadly-available-mexico 2021-10-10 https://www.invitae.com/en/press/invitae-and-tme-research-announce-landmark-new-study-evaluate-breast-cancer-patients 2021-10-10 https://www.invitae.com/en/press/invitae-announce-first-quarter-2015-financial-results 2021-10-10 https://www.invitae.com/en/press/invitae-announce-first-quarter-2016-financials 2021-10-10 https://www.invitae.com/en/press/invitae-announce-first-quarter-2017-financial-results-and-host-conference-call-may-8-2017 2021-10-10 https://www.invitae.com/en/press/invitae-announce-first-quarter-2018-financial-results-may-9-2018 2021-10-10 https://www.invitae.com/en/press/invitae-announce-first-quarter-2019-financial-results-may-7-2019 2021-10-10 https://www.invitae.com/en/press/invitae-announce-fourth-quarter-and-year-end-2014-financial-results-and-host-conference-call-march-10-2015 2021-10-10 https://www.invitae.com/en/press/invitae-announce-fourth-quarter-and-year-end-2016-financial-results 2021-10-10 https://www.invitae.com/en/press/invitae-announce-fourth-quarter-year-end-2015-Leerink 2021-10-10 https://www.invitae.com/en/press/invitae-announce-fourth-quarter-and-year-end-2017-financial-results-february-12-2018 2021-10-10 https://www.invitae.com/en/press/invitae-announce-second-quarter-2015-financial-results-and-host-conference-call-august-6-2015 2021-10-10 https://www.invitae.com/en/press/invitae-announce-second-quarter-2017-financial-results-and-host-conference-call-august-7-2017 2021-10-10 https://www.invitae.com/en/press/invitae-announce-second-quarter-2018-financial-results-august-7-2018 2021-10-10 https://www.invitae.com/en/press/invitae-announce-third-quarter-2016 2021-10-10 https://www.invitae.com/en/press/invitae-announce-third-quarter-2017-financial-results 2021-10-10 https://www.invitae.com/en/press/invitae-announce-third-quarter-2018-financial-results-november-7-2018 2021-10-10 https://www.invitae.com/en/press/invitae-announces-735-million-private-placement-offering-fuel-strategic-growth-opportunities-and-reports-preliminary-second-quarter-financial-results 2021-10-10 https://www.invitae.com/en/press/invitae-announces-availability-its-family-history-tool-free-family-history-collection-app-apples-app-store 2021-10-10 https://www.invitae.com/en/press/invitae-announces-completion-initial-public-offering-and-full-exercise-underwriters-option-purchase-additional-shares 2021-10-10 https://www.invitae.com/en/press/invitae-announces-exercise-full-underwriters-option-purchase-additional-shares-common-stock 2021-10-10 https://www.invitae.com/en/press/invitae-announces-expansion-sma-during-2017-acmg 2021-10-10 https://www.invitae.com/en/press/invitae-announces-exome-testing 2021-10-10 https://www.invitae.com/en/press/invitae-announces-first-quarter-2015-financial-results-and-highlights 2021-10-10 https://www.invitae.com/en/press/invitae-announces-fourth-quarter-and-2014-year-end-financial-results-and-highlights-and-provides-2015-outlook 2021-10-10 https://www.invitae.com/en/press/invitae-announces-new-education-program-increase-awareness-genetic-testing 2021-10-10 https://www.invitae.com/en/press/invitae-announces-new-program-offer-genetic-testing-aid-diagnosis-spinal-muscular-atrophy-sma 2021-10-10 https://www.invitae.com/en/press/invitae-announces-major-expansion-and-newborn-screening-confirmation 2021-10-10 https://www.invitae.com/en/press/invitae-announces-online-publication-data-comparing-traditional-and-multi-gene-panel-testing-hereditary-breast-and-ovarian-cancer-journal-molecular-diagnostics 2021-10-10 https://www.invitae.com/en/press/invitae-announces-pricing-initial-public-offering-common-stock 2021-10-10 https://www.invitae.com/en/press/invitae-announces-pricing-public-offering-common-stock 2021-10-10 https://www.invitae.com/en/press/invitae-announces-proposed-public-offering-common-stock 2021-10-10 https://www.invitae.com/en/press/invitae-announces-reimbursement-coverage-decision-blue-shield-california-and-acceptance-medicare-provider 2021-10-10 https://www.invitae.com/en/press/invitae-announces-results-hereditary-breast-cancer-study-collaboration-stanford-university 2021-10-10 https://www.invitae.com/en/press/invitae-announces-sean-george-participate-gene-panel-during-32nd-annual-jp-morgan-healthcare-conference 2021-10-10 https://www.invitae.com/en/press/invitae-announces-second-quarter-2016 2021-10-10 https://www.invitae.com/en/press/invitae-announces-settlement-lawsuit-myriad-genetics 2021-10-10 https://www.invitae.com/en/press/invitae-announces-third-quarter-2016-financial-results-secures-contracts-top-five-largest-payers-and-grows-volume-more-200-year-over-year 2021-10-10 https://www.invitae.com/en/press/invitae-appoints-chitra-nayak-its-board-directors 2021-10-10 https://www.invitae.com/en/press/invitae-appoints-christine-m-gorjanc-board-directors 2021-10-10 https://www.invitae.com/en/press/invitae-bank-america-2016-health-conference 2021-10-10 https://www.invitae.com/en/press/invitae-appoints-robert-nussbaum-md-chief-medical-officer 2021-10-10 https://www.invitae.com/en/press/invitae-breast-cancer-stat 2021-10-10 https://www.invitae.com/en/press/invitae-broadens-management-team 2021-10-10 https://www.invitae.com/en/press/invitae-bio-ceo-leerink-partners 2021-10-10 https://www.invitae.com/en/press/invitae-chile-presenting-future-genetic-medicine-santiago 2021-10-10 https://www.invitae.com/en/press/invitae-collaboration-helix 2021-10-10 https://www.invitae.com/en/press/invitae-clinvar-project 2021-10-10 https://www.invitae.com/en/press/invitae-carrier-screening 2021-10-10 https://www.invitae.com/en/press/invitae-commences-exchange-offer-combimatrix-series-f-warrants 2021-10-10 https://www.invitae.com/en/press/invitae-completes-40-million-series-e-financing 2021-10-10 https://www.invitae.com/en/press/invitae-completes-120-million-series-f-financing 2021-10-10 https://www.invitae.com/en/press/invitae-completes-acquisition-combimatrix 2021-10-10 https://www.invitae.com/en/press/invitae-corporation-files-registration-statement-proposed-initial-public-offering 2021-10-10 https://www.invitae.com/en/press/invitae-comprehensive-high-quality-affordable-genetic-testing-new-york-hereditary-cancer-cardiology-and-epilepsy 2021-10-10 https://www.invitae.com/en/press/invitae-corporation-issues-reminder-regarding-exchange-offer-combimatrix-corporation-series-f-warrants 2021-10-10 https://www.invitae.com/en/press/invitae-data-shows-increased-diagnosis-rates-custom-ngs-technique 2021-10-10 https://www.invitae.com/en/press/invitae-demonstrates-germline-multigene-panel-testing 2021-10-10 https://www.invitae.com/en/press/invitae-exceeds-26000-samples-accessioned-reports-revenue-103-million-and-net-loss-064-share-first-quarter-2017 2021-10-10 https://www.invitae.com/en/press/invitae-establishes-international-subsidiary-and-state-art-genetic-testing-facility-chile-partnership-biotech-pioneer-pablo-valenzuela 2021-10-10 https://www.invitae.com/en/press/invitae-expands-its-cardiology-offering 2021-10-10 https://www.invitae.com/en/press/invitae-expands-existing-credit-facility-provide-400-million-available-growth-capital 2021-10-10 https://www.invitae.com/en/press/invitae-expands-its-hereditary-cancer-offering 2021-10-10 https://www.invitae.com/en/press/invitae-expands-its-offering-rare-disease-and-pediatric 2021-10-10 https://www.invitae.com/en/press/invitae-expands-its-neuromuscular-offering 2021-10-10 https://www.invitae.com/en/press/invitae-expands-test-menu-proactive-genetic-testing 2021-10-10 https://www.invitae.com/en/press/invitae-expands-network-patients-rare-and-ultra-rare-diseases 2021-10-10 https://www.invitae.com/en/press/invitae-expands-test-menu 2021-10-10 https://www.invitae.com/en/press/sarepta-and-invitae-expand-partnership-advance-clinical-research-duchenne-muscular-dystrophy 2021-10-10 https://www.invitae.com/en/press/research-shows-high-positive-rate-risk-hereditary-disease-study-proactive-genetic-health-screening-healthy-people 2021-10-10 https://www.invitae.com/en/press/new-study-published-journal-clinical-oncology-supports-universal-genetic-testing-all-breast-cancer-patients 2021-10-10 https://www.invitae.com/en/press/research-underscores-need-updated-guidelines-include-multigene-testing-cancer-patients 2021-10-10 https://www.invitae.com/en/press/new-study-invitae-highlights-importance-multigene-genetic-testing-uterine-cancer-patients 2021-10-10 https://www.invitae.com/en/press/multigene-genetic-testing-improves-identification-and-management-hereditary-cancer-risk-breast-cancer-patients-and-their-families 2021-10-10 https://www.invitae.com/en/press/new-research-suggests-current-genetic-testing-guidelines-may-miss-breast-cancer-patients-who-could-benefit-testing 2021-10-10 https://www.invitae.com/en/press/joining-forces-locus-development 2021-10-10 https://www.invitae.com/en/press/invitae-to-announce-third-quarter-2015-financials 2021-10-10 https://www.invitae.com/en/press/morgan-stanley-healthcare-conference-announcement 2021-10-10 https://www.invitae.com/en/press/invitae-third-quarter-2017 2021-10-10 https://www.invitae.com/en/press/invitae-third-quarter-2015-financial-results 2021-10-10 https://www.invitae.com/en/press/invitae-sherloc 2021-10-10 https://www.invitae.com/en/press/invitae-second-quarter-2016-call-announcement 2021-10-10 https://www.invitae.com/en/press/invitae-responds-myriad-genetics-lawsuit 2021-10-10 https://www.invitae.com/en/press/invitae-reports-second-quarter-2017-results 2021-10-10 https://www.invitae.com/en/press/invitae-research-highlights-utility-proactive-genetic-screening-importance-assessing-secondary-findings-genetic-testing 2021-10-10 https://www.invitae.com/en/press/invitae-reports-over-150-volume-and-over-170-revenue-growth-2017 2021-10-10 https://www.invitae.com/en/press/invitae-reports-2018-preliminary-financial-results-delivering-more-100-volume-and-revenue-growth-2018-projects-sustained-growth-expanding-markets-through-2019-and-beyond 2021-10-10 https://www.invitae.com/en/press/invitae-reports-more-160-annual-revenue-growth-driven-nearly-140-annual-growth-volume-second-quarter-2018 2021-10-10 https://www.invitae.com/en/press/invitae-reports-169-revenue-growth-driven-150-growth-volume-first-quarter-2018 2021-10-10 https://www.invitae.com/en/press/invitae-reports-106-annual-revenue-growth-driven-95-annual-growth-volume-third-quarter-2018 2021-10-10 https://www.invitae.com/en/press/invitae-receives-accreditation-its-laboratory-college-american-pathologists 2021-10-10 https://www.invitae.com/en/press/invitae-raises-volume-guidance-announces-second-quarter-2015-financial-results 2021-10-10 https://www.invitae.com/en/press/invitae-provide-testing-sudden-death-young-sdy-case-registry-advance-understanding-sudden-death-young 2021-10-10 https://www.invitae.com/en/press/invitae-proposed-public-offering-common-stock 2021-10-10 https://www.invitae.com/en/press/invitae-presents-new-data-demonstrating-high-concordance-variant-classifications-brca12-across-major-clinical-testing-laboratories 2021-10-10 https://www.invitae.com/en/press/invitae-presents-new-data-NGS-multi-gene-panels-2015-ACMG-meeting 2021-10-10 https://www.invitae.com/en/press/invitae-pricing-public-offering-common-stock 2021-10-10 https://www.invitae.com/en/press/invitae-present-ubs-global-healthcare 2021-10-10 https://www.invitae.com/en/press/invitae-present-william-blair-28th-annual-growth-stock-conference 2021-10-10 https://www.invitae.com/en/press/invitae-presenting-NSGC-AEC 2021-10-10 https://www.invitae.com/en/press/invitae-present-ubs-global-healthcare-conference 2021-10-10 https://www.invitae.com/en/press/invitae-present-seventeen-posters-and-presentations-2017-ACMG 2021-10-10 https://www.invitae.com/en/press/invitae-present-goldman-sachs-38th-annual-global-healthcare-conference 2021-10-10 https://www.invitae.com/en/press/invitae-present-seven-posters-highlighting-new-data-use-next-generation-sequencing-multi-gene-panels-2015-american-college-medical-genetics-annual-clinical-genetics-meeting 2021-10-10 https://www.invitae.com/en/press/invitae-present-cowen-and-company-38th 2021-10-10 https://www.invitae.com/en/press/invitae-present-cowen-and-company-37th-conference 2021-10-10 https://www.invitae.com/en/press/invitae-present-cowen-health-care-conference 2021-10-10 https://www.invitae.com/en/press/invitae-present-canaccord-growth-conference 2021-10-10 https://www.invitae.com/en/press/invitae-present-cantor-fitzgerald-global-healthcare-conference 2021-10-10 https://www.invitae.com/en/press/invitae-present-canaccord-genuity-medical-technology-diagnostics-forum 2021-10-10 https://www.invitae.com/en/press/invitae-present-bank-america-merrill-lynch-2017-health-care 2021-10-10 https://www.invitae.com/en/press/invitae-present-36th-annual-jp-morgan-healthcare-conference 2021-10-10 https://www.invitae.com/en/press/invitae-present-2019-william-blair-growth-stock-conference 2021-10-10 https://www.invitae.com/en/press/invitae-present-8th-svb-leerink-hc-conference 2021-10-10 https://www.invitae.com/en/press/invitae-pre-earnings 2021-10-10 https://www.invitae.com/en/press/invitae-present-2016-ACMG 2021-10-10 https://www.invitae.com/en/press/invitae-posters-ASHG-data 2021-10-10 https://www.invitae.com/en/press/invitae-partners-kew-inc-develop-somatic-mutation-detection-capabilities-improve-cancer-care-providing-comprehensive-genomic-information 2021-10-10 https://www.invitae.com/en/press/invitae-partnership-alnylam 2021-10-10 https://www.invitae.com/en/press/invitae-participate-morgan-stanley-global-healthcare-conference 2021-10-10 https://www.invitae.com/en/press/invitae-oppenheimer-29th-healthcare-conference 2021-10-10 https://www.invitae.com/en/press/invitae-offers-palb2-testing-providing-clinicians-reliable-fast-affordable-option-patients 2021-10-10 https://www.invitae.com/en/press/invitae-offers-multi-gene-testing-hereditary-pancreatic-cancer-providing-clinicians-reliable-fast-affordable-option-patients 2021-10-10 https://www.invitae.com/en/press/invitae-offers-brca1brca2-testing-providing-clinicians-reliable-fast-affordable-option-patients 2021-10-10 https://www.invitae.com/en/press/invitae-new-leadership-structure-drive-global-growth 2021-10-10 https://www.invitae.com/en/press/invitae-new-research-suite-services-NSGC 2021-10-10 https://www.invitae.com/en/press/invitae-more-doubles-annual-volume-exceeds-full-year-2017-guidance-and-projects-momentum-continue-2018 2021-10-10 https://www.invitae.com/en/press/invitae-met-volume-guidance-sets-2016-volume-guidance 2021-10-10 https://www.invitae.com/en/press/invitae-nccn-annual-conference-utility-multi-gene-panels 2021-10-10 https://www.invitae.com/en/press/invitae-medicare-reimbursement 2021-10-10 https://www.invitae.com/en/press/invitae-medicare-pricing-set-925 2021-10-10 https://www.invitae.com/en/press/invitae-launches-new-patient-pay-price-475-its-full-menu-genetic-tests 2021-10-10 https://www.invitae.com/en/press/invitae-major-expansion-pediatric-neurological-rare 2021-10-10 https://www.invitae.com/en/press/invitae-launches-NIPS 2021-10-10 https://www.invitae.com/en/press/invitae-launch-patient-insights-network 2021-10-10 https://www.invitae.com/en/press/invitae-launch-cancercheck-ASCO 2021-10-10 https://www.invitae.com/en/press/invitae-jama-oncology 2021-10-10 https://www.invitae.com/en/press/invitae-increase-prostate-cancer-genetic-tests 2021-10-10 https://www.invitae.com/en/press/invitae-full-year-2015-financial-2016-business-objectives 2021-10-10 https://www.invitae.com/en/press/invitae-highlighting-new-research-honoring-excellence-genetic-counseling-national-society-genetic-counselors-nsgc-37th-annual-conference 2021-10-10 https://www.invitae.com/en/press/invitae-first-quarter-2016-financial-results 2021-10-10 https://www.invitae.com/en/press/invitae-expansion-test-menu-metabolic-immune-system-disorders-newborn-screening 2021-10-10 https://www.invitae.com/en/press/invitae-files-suit-against-myriad-genetics 2021-10-10 https://www.invitae.com/en/press/invitae-expansion-neurology-and-cardiology 2021-10-10 https://www.invitae.com/en/press/invitae-fourth-quarter-2016-and-projects-strong-volume-and-revenue-growth-2017 2021-10-10 https://www.invitae.com/en/press/invitae-expansion-hereditary-cancer-menu 2021-10-10 https://www.invitae.com/en/press/invitae-expansion-epilepsy-test-menu 2021-10-10 https://www.invitae.com/en/press/invitae-expands-work-alnylam-pharmaceuticals-provide-access-genetic-testing-primary-hyperoxaluria 2021-10-10